CN Stock MarketDetailed Quotes

603087 Gan & Lee Pharmaceuticals.

Watchlist
  • 45.77
  • +0.24+0.53%
Not Open Dec 20 15:00 CST
27.51BMarket Cap47.38P/E (TTM)

Gan & Lee Pharmaceuticals. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
17.81%2.25B
6.92%1.31B
0.42%560.33M
52.31%2.61B
54.07%1.91B
47.31%1.23B
-19.13%558M
-52.60%1.71B
-50.59%1.24B
-43.42%834.8M
Operating revenue
17.81%2.25B
6.92%1.31B
0.42%560.33M
52.31%2.61B
54.07%1.91B
47.31%1.23B
-19.13%558M
-52.60%1.71B
-50.59%1.24B
-43.42%834.8M
Other operating revenue
----
43.05%3.41M
----
383.81%11.6M
----
--2.38M
----
2,027.18%2.4M
----
--0
Total operating cost
16.77%1.92B
6.60%1.18B
2.63%541.95M
3.49%2.31B
1.72%1.65B
6.22%1.11B
5.59%528.08M
10.24%2.23B
0.79%1.62B
0.27%1.04B
Operating cost
14.97%553.24M
8.20%349.1M
0.94%152.25M
71.86%697.42M
77.72%481.19M
110.91%322.66M
149.91%150.83M
2.45%405.8M
-4.97%270.76M
-11.01%152.99M
Operating tax surcharges
24.05%22.25M
15.57%14.44M
3.36%6.26M
15.79%24.26M
10.28%17.93M
8.55%12.49M
1.57%6.06M
-20.05%20.95M
-12.82%16.26M
-2.18%11.51M
Operating expense
18.15%831.33M
5.53%490.98M
1.05%227.09M
-12.94%945.95M
-15.19%703.63M
-17.64%465.24M
-21.99%224.73M
8.35%1.09B
13.58%829.62M
14.89%564.86M
Administration expense
20.01%169.96M
1.99%102.7M
-7.48%43.3M
-12.39%216.75M
-21.29%141.63M
-14.38%100.7M
-33.84%46.8M
-17.24%247.39M
-24.35%179.93M
-23.10%117.61M
Financial expense
14.64%-58.46M
23.10%-41.64M
1.06%-20.07M
16.51%-78.72M
4.63%-68.49M
-14.05%-54.14M
11.34%-20.28M
46.69%-94.29M
-314.19%-71.81M
-357.52%-47.47M
Research and development
9.05%403.44M
1.72%266.48M
10.99%133.12M
-10.92%501.02M
-5.91%369.95M
7.17%261.96M
22.52%119.94M
18.52%562.47M
12.10%393.2M
9.49%244.43M
Credit Impairment Loss
-88.22%529.4K
-82.45%961.33K
----
41.41%-15.96M
129.09%4.49M
167.46%5.48M
527.91%5.18M
-40.53%-27.25M
-547.85%-15.44M
-167.28%-8.12M
Asset Impairment Loss
100.50%16.82K
100.39%16.82K
--49.62K
49.61%-39.83M
83.48%-3.35M
---4.33M
----
-1,988.10%-79.04M
---20.29M
----
Other net revenue
316.52%239.02M
378.19%206.51M
216.80%94.74M
126.65%13.93M
221.54%57.39M
473.54%43.19M
156.38%29.9M
-148.13%-52.27M
-137.26%-47.22M
-80.55%7.53M
Fair value change income
1,055.27%167.9M
1,456.51%154.13M
382.89%85.5M
77.79%-17.92M
87.19%-17.58M
114.74%9.9M
127.34%17.71M
-48.11%-80.66M
-1,514.28%-137.24M
-198.47%-67.18M
Invest income
-6.67%55.85M
96.83%41.4M
43.51%2.27M
-27.68%63.33M
-34.49%59.84M
-70.65%21.03M
-71.99%1.58M
-37.49%87.57M
-4.84%91.35M
174.10%71.68M
Asset deal income
1,335.98%658K
1,129.40%563.34K
312.83%580.91K
-30.17%339.27K
3,111.35%45.82K
3,111.35%45.82K
--140.72K
48,659.15%485.85K
-100.39%-1.52K
-100.30%-1.52K
Other revenue
0.92%14.07M
-14.61%9.44M
19.72%6.34M
-48.59%23.97M
-59.49%13.94M
-0.84%11.05M
0.66%5.3M
0.98%46.62M
-16.50%34.41M
-70.35%11.15M
Operating profit
77.25%562.26M
106.87%339.35M
89.07%113.12M
155.42%315.29M
174.06%317.21M
181.37%164.04M
-56.27%59.83M
-133.48%-568.87M
-141.80%-428.3M
-142.62%-201.6M
Add:Non operating Income
-26.15%2.16M
-17.91%1.79M
619.41%519.78K
40.11%4.12M
29.20%2.93M
141.12%2.19M
23.75%72.25K
16.46%2.94M
915.78%2.27M
1,327.41%906.5K
Less:Non operating expense
-91.03%818.06K
-95.55%290.7K
-96.59%75.27K
-19.80%13.27M
32.66%9.12M
105.88%6.54M
8,821.39%2.21M
204.93%16.54M
81.44%6.88M
-0.71%3.17M
Total profit
81.21%563.6M
113.44%340.85M
96.84%113.56M
152.56%306.14M
171.85%311.02M
178.33%159.69M
-57.84%57.69M
-134.34%-582.47M
-142.40%-432.91M
-143.39%-203.87M
Less:Income tax cost
26.48%56.34M
64.26%41.95M
107.34%17.56M
76.15%-34.09M
333.23%44.55M
508.07%25.54M
-64.05%8.47M
-158.77%-142.96M
-112.77%-19.1M
-106.44%-6.26M
Net profit
90.36%507.27M
122.80%298.9M
95.04%96M
177.41%340.23M
164.40%266.48M
167.89%134.16M
-56.55%49.22M
-130.25%-439.52M
-147.49%-413.81M
-153.01%-197.61M
Net profit from continuing operation
90.36%507.27M
122.80%298.9M
95.04%96M
177.41%340.23M
164.40%266.48M
167.89%134.16M
-56.55%49.22M
-130.25%-439.52M
-147.49%-413.81M
-153.01%-197.61M
Less:Minority Profit
-39.02%-46.17
-22.21%-46.17
-2.51%-44.47
712,164.47%162.92K
-16.28%-33.21
-6.81%-37.78
-2.67%-43.38
89.48%-22.88
87.27%-28.56
84.70%-35.37
Net profit of parent company owners
90.36%507.27M
122.80%298.9M
95.04%96M
177.37%340.07M
164.40%266.48M
167.89%134.16M
-56.55%49.22M
-130.25%-439.52M
-147.49%-413.81M
-153.01%-197.61M
Earning per share
Basic earning per share
80.85%0.85
112.50%0.51
77.78%0.16
176.92%0.6
163.51%0.47
168.57%0.24
-55.00%0.09
-130.12%-0.78
-147.74%-0.74
-153.03%-0.35
Diluted earning per share
80.85%0.85
112.50%0.51
77.78%0.16
176.92%0.6
163.51%0.47
168.57%0.24
-55.00%0.09
-130.12%-0.78
-147.74%-0.74
-153.03%-0.35
Other composite income
-199.52%-865.26K
-107.72%-138.14K
90.12%-110.99K
-94.55%375.3K
-89.86%869.46K
-55.34%1.79M
-254.94%-1.12M
464.32%6.88M
535.72%8.57M
282.13%4.01M
Other composite income of parent company owners
-199.52%-865.26K
-107.72%-138.14K
90.12%-110.99K
-94.55%375.3K
-89.86%869.46K
-55.34%1.79M
-254.94%-1.12M
464.32%6.88M
--8.57M
282.13%4.01M
Total composite income
89.42%506.4M
119.77%298.77M
99.36%95.89M
178.73%340.61M
165.97%267.35M
170.22%135.94M
-57.43%48.1M
-129.82%-432.63M
-146.61%-405.23M
-152.24%-193.6M
Total composite income of parent company owners
89.42%506.4M
119.77%298.77M
99.36%95.89M
178.69%340.44M
165.97%267.35M
170.22%135.94M
-57.43%48.1M
-129.82%-432.63M
-146.61%-405.23M
-152.24%-193.6M
Total composite income of minority owners
-39.02%-46.17
-22.21%-46.17
-2.51%-44.47
712,164.47%162.92K
-16.28%-33.21
-6.81%-37.78
-2.67%-43.38
89.48%-22.88
87.27%-28.56
84.70%-35.37
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 17.81%2.25B6.92%1.31B0.42%560.33M52.31%2.61B54.07%1.91B47.31%1.23B-19.13%558M-52.60%1.71B-50.59%1.24B-43.42%834.8M
Operating revenue 17.81%2.25B6.92%1.31B0.42%560.33M52.31%2.61B54.07%1.91B47.31%1.23B-19.13%558M-52.60%1.71B-50.59%1.24B-43.42%834.8M
Other operating revenue ----43.05%3.41M----383.81%11.6M------2.38M----2,027.18%2.4M------0
Total operating cost 16.77%1.92B6.60%1.18B2.63%541.95M3.49%2.31B1.72%1.65B6.22%1.11B5.59%528.08M10.24%2.23B0.79%1.62B0.27%1.04B
Operating cost 14.97%553.24M8.20%349.1M0.94%152.25M71.86%697.42M77.72%481.19M110.91%322.66M149.91%150.83M2.45%405.8M-4.97%270.76M-11.01%152.99M
Operating tax surcharges 24.05%22.25M15.57%14.44M3.36%6.26M15.79%24.26M10.28%17.93M8.55%12.49M1.57%6.06M-20.05%20.95M-12.82%16.26M-2.18%11.51M
Operating expense 18.15%831.33M5.53%490.98M1.05%227.09M-12.94%945.95M-15.19%703.63M-17.64%465.24M-21.99%224.73M8.35%1.09B13.58%829.62M14.89%564.86M
Administration expense 20.01%169.96M1.99%102.7M-7.48%43.3M-12.39%216.75M-21.29%141.63M-14.38%100.7M-33.84%46.8M-17.24%247.39M-24.35%179.93M-23.10%117.61M
Financial expense 14.64%-58.46M23.10%-41.64M1.06%-20.07M16.51%-78.72M4.63%-68.49M-14.05%-54.14M11.34%-20.28M46.69%-94.29M-314.19%-71.81M-357.52%-47.47M
Research and development 9.05%403.44M1.72%266.48M10.99%133.12M-10.92%501.02M-5.91%369.95M7.17%261.96M22.52%119.94M18.52%562.47M12.10%393.2M9.49%244.43M
Credit Impairment Loss -88.22%529.4K-82.45%961.33K----41.41%-15.96M129.09%4.49M167.46%5.48M527.91%5.18M-40.53%-27.25M-547.85%-15.44M-167.28%-8.12M
Asset Impairment Loss 100.50%16.82K100.39%16.82K--49.62K49.61%-39.83M83.48%-3.35M---4.33M-----1,988.10%-79.04M---20.29M----
Other net revenue 316.52%239.02M378.19%206.51M216.80%94.74M126.65%13.93M221.54%57.39M473.54%43.19M156.38%29.9M-148.13%-52.27M-137.26%-47.22M-80.55%7.53M
Fair value change income 1,055.27%167.9M1,456.51%154.13M382.89%85.5M77.79%-17.92M87.19%-17.58M114.74%9.9M127.34%17.71M-48.11%-80.66M-1,514.28%-137.24M-198.47%-67.18M
Invest income -6.67%55.85M96.83%41.4M43.51%2.27M-27.68%63.33M-34.49%59.84M-70.65%21.03M-71.99%1.58M-37.49%87.57M-4.84%91.35M174.10%71.68M
Asset deal income 1,335.98%658K1,129.40%563.34K312.83%580.91K-30.17%339.27K3,111.35%45.82K3,111.35%45.82K--140.72K48,659.15%485.85K-100.39%-1.52K-100.30%-1.52K
Other revenue 0.92%14.07M-14.61%9.44M19.72%6.34M-48.59%23.97M-59.49%13.94M-0.84%11.05M0.66%5.3M0.98%46.62M-16.50%34.41M-70.35%11.15M
Operating profit 77.25%562.26M106.87%339.35M89.07%113.12M155.42%315.29M174.06%317.21M181.37%164.04M-56.27%59.83M-133.48%-568.87M-141.80%-428.3M-142.62%-201.6M
Add:Non operating Income -26.15%2.16M-17.91%1.79M619.41%519.78K40.11%4.12M29.20%2.93M141.12%2.19M23.75%72.25K16.46%2.94M915.78%2.27M1,327.41%906.5K
Less:Non operating expense -91.03%818.06K-95.55%290.7K-96.59%75.27K-19.80%13.27M32.66%9.12M105.88%6.54M8,821.39%2.21M204.93%16.54M81.44%6.88M-0.71%3.17M
Total profit 81.21%563.6M113.44%340.85M96.84%113.56M152.56%306.14M171.85%311.02M178.33%159.69M-57.84%57.69M-134.34%-582.47M-142.40%-432.91M-143.39%-203.87M
Less:Income tax cost 26.48%56.34M64.26%41.95M107.34%17.56M76.15%-34.09M333.23%44.55M508.07%25.54M-64.05%8.47M-158.77%-142.96M-112.77%-19.1M-106.44%-6.26M
Net profit 90.36%507.27M122.80%298.9M95.04%96M177.41%340.23M164.40%266.48M167.89%134.16M-56.55%49.22M-130.25%-439.52M-147.49%-413.81M-153.01%-197.61M
Net profit from continuing operation 90.36%507.27M122.80%298.9M95.04%96M177.41%340.23M164.40%266.48M167.89%134.16M-56.55%49.22M-130.25%-439.52M-147.49%-413.81M-153.01%-197.61M
Less:Minority Profit -39.02%-46.17-22.21%-46.17-2.51%-44.47712,164.47%162.92K-16.28%-33.21-6.81%-37.78-2.67%-43.3889.48%-22.8887.27%-28.5684.70%-35.37
Net profit of parent company owners 90.36%507.27M122.80%298.9M95.04%96M177.37%340.07M164.40%266.48M167.89%134.16M-56.55%49.22M-130.25%-439.52M-147.49%-413.81M-153.01%-197.61M
Earning per share
Basic earning per share 80.85%0.85112.50%0.5177.78%0.16176.92%0.6163.51%0.47168.57%0.24-55.00%0.09-130.12%-0.78-147.74%-0.74-153.03%-0.35
Diluted earning per share 80.85%0.85112.50%0.5177.78%0.16176.92%0.6163.51%0.47168.57%0.24-55.00%0.09-130.12%-0.78-147.74%-0.74-153.03%-0.35
Other composite income -199.52%-865.26K-107.72%-138.14K90.12%-110.99K-94.55%375.3K-89.86%869.46K-55.34%1.79M-254.94%-1.12M464.32%6.88M535.72%8.57M282.13%4.01M
Other composite income of parent company owners -199.52%-865.26K-107.72%-138.14K90.12%-110.99K-94.55%375.3K-89.86%869.46K-55.34%1.79M-254.94%-1.12M464.32%6.88M--8.57M282.13%4.01M
Total composite income 89.42%506.4M119.77%298.77M99.36%95.89M178.73%340.61M165.97%267.35M170.22%135.94M-57.43%48.1M-129.82%-432.63M-146.61%-405.23M-152.24%-193.6M
Total composite income of parent company owners 89.42%506.4M119.77%298.77M99.36%95.89M178.69%340.44M165.97%267.35M170.22%135.94M-57.43%48.1M-129.82%-432.63M-146.61%-405.23M-152.24%-193.6M
Total composite income of minority owners -39.02%-46.17-22.21%-46.17-2.51%-44.47712,164.47%162.92K-16.28%-33.21-6.81%-37.78-2.67%-43.3889.48%-22.8887.27%-28.5684.70%-35.37
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Medical Device Concept
Medical Device Concept
Intraday+0.57%